Articles

Meaningful changes in end-of-life care among patients with myeloma

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA;Center for Lymphoma, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA
Center for Myeloma, Dana-Farber Cancer Institute, Boston, MA, USA
Center for Myeloma, Dana-Farber Cancer Institute, Boston, MA, USA
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA;Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Vol. 103 No. 8 (2018): August, 2018 https://doi.org/10.3324/haematol.2018.187609